Schedule 13G ownership disclosure

ESPERION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 29664W105

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001382333-20-000003
Form type
SC 13G/A
Filer
Esperion Therapeutics, Inc.
CIK
CIK 1434868
Filed
Jan 03, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub